A detailed history of Banque Pictet & Cie Sa transactions in Castle Biosciences Inc stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 166,881 shares of CSTL stock, worth $3.63 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
166,881
Previous 182,664 8.64%
Holding current value
$3.63 Million
Previous $3.94 Million 6.22%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$18.06 - $25.3 $285,040 - $399,309
-15,783 Reduced 8.64%
166,881 $3.7 Million
Q4 2023

Feb 09, 2024

SELL
$12.19 - $22.43 $251,248 - $462,304
-20,611 Reduced 10.14%
182,664 $3.94 Million
Q3 2023

Nov 02, 2023

BUY
$13.28 - $20.3 $258,588 - $395,281
19,472 Added 10.59%
203,275 $3.43 Million
Q2 2023

Aug 04, 2023

SELL
$11.66 - $26.0 $76,746 - $171,132
-6,582 Reduced 3.46%
183,803 $2.52 Million
Q1 2023

May 01, 2023

SELL
$19.47 - $28.49 $273,203 - $399,771
-14,032 Reduced 6.86%
190,385 $4.33 Million
Q4 2022

Feb 06, 2023

SELL
$18.08 - $30.0 $782,882 - $1.3 Million
-43,301 Reduced 17.48%
204,417 $0
Q3 2022

Nov 10, 2022

BUY
$22.51 - $34.32 $2.15 Million - $3.28 Million
95,652 Added 62.9%
247,718 $6.46 Billion
Q2 2022

Aug 08, 2022

SELL
$16.0 - $45.99 $90,016 - $258,739
-5,626 Reduced 3.57%
152,066 $3.34 Million
Q1 2022

May 04, 2022

SELL
$33.17 - $46.98 $48,030 - $68,027
-1,448 Reduced 0.91%
157,692 $7.07 Million
Q4 2021

Feb 02, 2022

BUY
$39.06 - $67.58 $5.2 Million - $9 Million
133,137 Added 512.01%
159,140 $6.82 Million
Q3 2021

Nov 10, 2021

BUY
$60.13 - $77.6 $177,563 - $229,152
2,953 Added 12.81%
26,003 $1.73 Million
Q2 2021

Aug 12, 2021

BUY
$50.07 - $76.78 $54,426 - $83,459
1,087 Added 4.95%
23,050 $1.69 Million
Q1 2021

May 11, 2021

BUY
$58.92 - $97.33 $1.29 Million - $2.14 Million
21,963 New
21,963 $1.5 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $572M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.